505 related articles for article (PubMed ID: 3951199)
1. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
2. Role of neutrophils in the deposition of platelets during acute inflammation.
Issekutz AC; Ripley M; Jackson JR
Lab Invest; 1983 Dec; 49(6):716-24. PubMed ID: 6361376
[TBL] [Abstract][Full Text] [Related]
3. A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin.
Hellewell PG; Williams TJ
J Immunol; 1986 Jul; 137(1):302-7. PubMed ID: 2940300
[TBL] [Abstract][Full Text] [Related]
4. Effect of vasoactive agents on polymorphonuclear leukocyte emigration in vivo.
Issekutz AC
Lab Invest; 1981 Sep; 45(3):234-40. PubMed ID: 6944561
[TBL] [Abstract][Full Text] [Related]
5. Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.
Pons F; Rossi AG; Norman KE; Williams TJ; Nourshargh S
Br J Pharmacol; 1993 May; 109(1):234-42. PubMed ID: 8495241
[TBL] [Abstract][Full Text] [Related]
6. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
7. Vascular responses during acute neutrophilic inflammation. Their relationship to in vivo neutrophil emigration.
Issekutz AC
Lab Invest; 1981 Nov; 45(5):435-41. PubMed ID: 7029133
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Doebber TW; Wu MS; Biftu T
J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
Angle MJ; McManus LM; Pinckard RN
Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
[TBL] [Abstract][Full Text] [Related]
10. Production of platelet-activating factor in inflammatory exudate.
Oh-ishi S; Imai Y; Hayashi M
J Lipid Mediat; 1992; 5(2):115-20. PubMed ID: 1525350
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
Hwang SB; Li CL; Lam MH; Shen TY
Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig.
Handley DA; Lee ML; Saunders RN
Thromb Haemost; 1985 Dec; 54(4):756-9. PubMed ID: 4089809
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of acute inflammatory lesions to chemotaxins and endotoxin.
Colditz IG; Movat HZ
J Immunol; 1984 Oct; 133(4):2163-8. PubMed ID: 6088633
[TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
15. [The role of platelet activating factor in ovulation].
Kikukawa Y; Ishikawa M; Sengoku K; Shimizu T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jun; 42(6):573-8. PubMed ID: 2401830
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the reversed passive Arthus and local Shwartzman reactions of rabbit skin: effects of the long-acting PAF antagonist UK-74,505.
Norman KE; Williams TJ; Rossi AG
Br J Pharmacol; 1997 Apr; 120(7):1286-93. PubMed ID: 9105704
[TBL] [Abstract][Full Text] [Related]
17. Receptor antagonist of platelet activating factor inhibits inflammatory injury induced by in situ formation of immune complexes in renal glomeruli and in the skin.
Camussi G; Pawlowski I; Saunders R; Brentjens J; Andres G
J Lab Clin Med; 1987 Aug; 110(2):196-206. PubMed ID: 2955066
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
Casals-Stenzel J; Muacevic G; Weber KH
J Pharmacol Exp Ther; 1987 Jun; 241(3):974-81. PubMed ID: 3598913
[TBL] [Abstract][Full Text] [Related]
19. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
